论文部分内容阅读
我们自1998年9月～2000年3月,在常规治疗基础上加用静滴丙种球蛋白(IVIG)治疗婴幼儿喘息性支气炎,取得较好疗效,现报告如下.1 资料与方法1.1 一般资料:78例患儿均符合婴幼儿喘息性支气管炎诊断标准.所有患儿有咳喘、气促、肺部哮鸣音,喘息发作均不超过2次,评分<4分.按完全随机方法分成两组,观察组男22例,女16例,年龄6个月～1岁18例,～2岁13例,～3岁7例.伴发热11例,伴腹泻13例;对照组男24例,女16例,6月～1岁19例,～2岁15例,～3岁6例,伴发热10例,伴腹泻11例.治疗前两组间相关资料差异均无显著性(P>0.05).
We from September 1998 ~ March 2000, in addition to conventional treatment based on the addition of intravenous gamma globulin (IVIG) treatment of infantile asthmatic bronchitis, and achieved good results, are reported as follows.1 Materials and Methods 1.1 General information: 78 children are in line with the diagnostic criteria for infants and young children asthmatic bronchitis.All children with cough, shortness of breath, lung wheeze, wheezing were less than 2 times, score <4. According to completely random Methods The patients were divided into two groups: 22 males and 16 females, 18 cases aged 6 months to 1 year, 13 cases aged 2 years, 7 cases aged 3 years, 11 cases with fever and 13 cases with diarrhea. The control group 24 cases, 16 females, 19 cases in June ~ 1 year old, 15 cases ~ 2 years old, 6 cases ~ 3 years old, 10 cases with fever and 11 cases with diarrhea.No significant difference was found between the two groups before treatment P> 0.05).